Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.43 |
| ▸ | BCAT1 | P54687 | 8/20 | 0.43 |
| ▸ | BCAT2 | O15382 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 3/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24171772 | 0.83 | ALDH1A1 (0.48) | ALDH1A1CYP2C9CYP2C19SMN1; SMN2KDM4E | |
| SCHEMBL5164597 | 0.76 | ALDH1A1 (0.50) | ALDH1A1CYP2C9CYP2C19SMN1; SMN2KDM4E | |
| SCHEMBL11925125 | 0.76 | CYP3A4 (0.46) | ALDH1A1KDM4ECYP3A4CYP2B6POLB | |
| SCHEMBL24961532 | 0.73 | KDM4E (0.50) | ALDH1A1CYP2C9CYP2C19SMN1; SMN2KDM4E | |
| SCHEMBL10855053 | 0.72 | CYP3A4 (0.50) | ALDH1A1SMN1; SMN2KDM4ECYP3A4CYP2B6 | |
| SCHEMBL1944948 | 0.72 | CYP3A4 (0.46) | ALDH1A1KDM4ECYP3A4CYP2B6POLB | |
| SCHEMBL9032574 | 0.70 | BCAT1 (0.46) | ALDH1A1CYP2C9CYP2C19SMN1; SMN2BCAT1 | |
| SCHEMBL13456857 | 0.69 | CYP3A4 (0.59) | ALDH1A1SMN1; SMN2KDM4ECYP3A4CYP2B6 | |
| SCHEMBL10033282 | 0.68 | CYP3A4 (0.43) | ALDH1A1KDM4ECYP3A4CYP2B6POLB | |
| SCHEMBL16324979 | 0.67 | CYP3A4 (0.64) | SMN1; SMN2CYP3A4CYP2B6POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3981715-A | 2,3,5-Substituted-6-trifluoromethyl-1,3-diazin-4-ones herbicides | AMERICAN CYANAMID COMPANY (US) | 1976-09-21 | — | — | US | claimed |
| US-20200172527-A1 | BENZOXAZINONE DERIVATIVES USEFUL AS HERBICIDES | REDAG CROP PROT LTD (GB) | 2020-06-04 | — | — | US | disclosed |
| EP-1150962-B1 | PROCESS FOR THE PREPARATION OF 6-(PERFLUOROALKYL)URACIL COMPOUNDS FROM CARBAMATE COMPOUNDS | AMERICAN CYANAMID CO (US) | 2004-04-28 | — | — | EP | disclosed |
| US-6355796-B1 | REACTING BETA-AMINO-BETA-(PERFLUOROALKYL)ACRYLATE COMPOUND WITH BASE AND CARBAMOYL CHLORIDE COMPOUND TO FORM UREA COMPOUND, REACTING UREA COMPOUND WITH PHOSPHORUS PENTAHALIDE OR OXALYL HALIDE | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-12 | — | — | US | disclosed |
| US-6313295-B1 | REACTING CARBAMATE WITH AMINE; CYCLIZATION, ALKYLATION | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-06 | — | — | US | disclosed |
| US-6140270-A | BY REACTING THEM WITH AN AMINE COMPOUND AND AN ACID OR BASE; HERBICIDES | AMERICAN CYANAMID COMPANY | 2000-10-31 | — | — | US | disclosed |
| US-3981715-A | 2,3,5-Substituted-6-trifluoromethyl-1,3-diazin-4-ones herbicides | AMERICAN CYANAMID COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172527-A1 | BENZOXAZINONE DERIVATIVES USEFUL AS HERBICIDES | CBR3, CBR1, CYP4X1 | ALDH1A1 336/4885CYP2C9 62/4885CYP2C19 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.